Cited by 112Hyperglycemia and glycemic control in critically ill and hospitalized patientsClinical Nutrition and GastroenterologyDiet, Metabolism, and Disease

Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group

Open access
Barazzoni, R., Deutz, N.E.P., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., Cuerda, C., Delzenne, N. +12 more·2017·Clinical Nutrition

Abstract

Growing evidence underscores the important role of glycemic control in health and recovery from illness. Carbohydrate ingestion in the diet or administration in nutritional support is mandatory, but carbohydrate intake can adversely affect major body organs and tissues if resulting plasma glucose becomes too high, too low, or highly variable. Plasma glucose control is especially important for patients with conditions such as diabetes or metabolic stress resulting from critical illness or surgery. These patients are particularly in need of glycemic management to help lessen glycemic variability and its negative health consequences when nutritional support is administered. Here we report on recent findings and emerging trends in the field based on an ESPEN workshop held in Venice, Italy, 8-9 November 2015. Evidence was discussed on pathophysiology, clinical impact, and nutritional recommendations for carbohydrate utilization and management in nutritional support. The main conclusions were: a) excess glucose and fructose availability may exacerbate metabolic complications in skeletal muscle, adipose tissue, and liver and can result in negative clinical impact; b) low-glycemic index and high-fiber diets, including specialty products for nutritional support, may provide metabolic and clinical benefits in individuals with obesity, insulin resistance, and diabetes; c) in acute conditions such as surgery and critical illness, insulin resistance and elevated circulating glucose levels have a negative impact on patient outcomes and should be prevented through nutritional and/or pharmacological intervention. In such acute settings, efforts should be implemented towards defining optimal plasma glucose targets, avoiding excessive plasma glucose variability, and optimizing glucose control relative to nutritional support.

Integrity signals

Registry

Crossref · 10.1016/j.clnu.2016.09.010

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Diabetic-specific enteral formula may have clinical and economic impact in ICU patients with Type 2 Diabetes Mellitus.

    “The use of diabetic-specific enteral formula in ICU patients suffering from Type 2 Diabetes Mellitus seems to improve the glucose profile (190,191) and may have clinical and economic impact (192).”

Cites

1 retracted

Flagged first, then by citations

2 of the 135 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Barazzoni, R., Deutz, N. E. P., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., Cuerda, C., Delzenne, N., Leon Sanz, M., Ljungqvist, O., Muscaritoli, M., Pichard, C., Preiser, J. C., Sbraccia, P., Singer, P., Tappy, L., Thorens, B., Van Gossum, A., Vettor, R., & Calder, P. C.
Affiliations
  • University of Trieste (IT)
  • Texas A&M University (US)
  • University of Hohenheim (DE)
  • Uppsala University (SE)
  • Hospital General Universitario Gregorio Marañón (ES)
  • UCLouvain (BE)
  • Örebro University (SE)
  • Sapienza University of Rome (IT)
  • University Hospital of Geneva (CH)
  • Erasmus Hospital (BE)
  • University of Rome Tor Vergata (IT)
  • Tel Aviv University (IL)
  • University of Lausanne (CH)
  • SIB Swiss Institute of Bioinformatics (CH)
  • University of Padua (IT)
  • University Hospital Southampton NHS Foundation Trust (GB)
Corresponding author
Barazzoni, R.
Venue
Clinical Nutrition
Publisher
Elsevier BV
Published
2017-04
Volume
36
Issue
2
Pages
355-363
ISSN
0261-5614 (ISSN-L)
OpenAlex
W2522546676
Cited by
112
References
135
Citations by year
2026: 9 · 2025: 10 · 2024: 9 · 2023: 14 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 10 · 2018: 13 · 2017: 10
FWCI
1.62
Type
journal article
Language
en
Open access
Locations
  • Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by-nc-nd)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • Digital Access to Libraries (submittedVersion, other-oa)
  • IRIS (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
carbohydrates, insulin resistance, glycemic control, nutritional support, plasma glucose, glycemic variability, fructose, low glycemic index diet, high-fiber diet, critical illness, diabetes mellitus, obesity, skeletal muscle, adipose tissue, liver
MeSH terms
Blood Glucose, Diet, Dietary Carbohydrates, Humans, Hyperglycemia, Hypoglycemia, Insulin Resistance, Italy, Nutritional Requirements, Risk Factors, Societies, Scientific, Nutritional Support, Nutrition Policy, Evidence-Based Medicine, Glycemic Index, Carbohydrate Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review